Salk News: Researchers find obesity receptor

La Jolla, Calif.A cellular receptor that balances the accumulation of fat and fat burning in the body may be a new target for anti-obesity and cholesterol-fighting drugs, according to a Salk Institute study.

The study, published in the April 18 issue of Cell, identified the function of this key receptor for the first time. The receptor, called PPARd, was found to regulate how fat is used and could point the way to new treatments for obesity as well as its associated lethal medical complications: type II diabetes, cardiovascular disease, hypertension and atherosclerosis.

Professor Ronald M. Evans, the March of Dimes Chair in Developmental and Molecular Biology at the Salk Institute and Howard Hughes Medical Institute investigator, and his team found that stimulating PPARd -- short for peroxisome proliferators-activated receptor -- depleted fat deposits in mice, while mice deficient in PPARd were prone to obesity.

PPARd was shown to regulate the rate by which fat is burned to produce heat or is used to maintain normal cell functions. The process of uncoupling energy from work production to heat generation, known as adaptive thermogenesis, is generally regarded as a physiological defense against obesity.

We have long known that excess calories are warehoused in fat tissue for future use, said Evans. We also know that fat is released and consumed in times when energy is needed, such as from exercise or shivering from cold exposure. This study shows us that PPARd is an important regulator of this function. By exploiting PPARd, we hope to design drugs that can control how much fat is stored in the body.

The team found that mice with an activated PPARd gene weighed about 20 percent less than normal mice, even though both groups received the same food at the same rate. Once the mice were a year old, the difference in weight widened, to 35 percent less for the genetically active PPARd mice.

At the same time, activated PPARd

Contact: Robert Bradford
Salk Institute

Page: 1 2

Related biology news :

1. Salk News: Institute receives $30 million gift
2. Salk News: Social behavior genes
3. Good News: Cognitive decline after bypass surgery mostly temporary and reversible
4. Sea Grant News: Caulerpa, DNA water quality detectives, Kayaking in Maine
5. DBI News: Plant microbe interactions and nutrient use to be explored Nov. 16 at UD
6. UD News: Gene-repair pioneer, Eric Kmiec, brings his lab to the University of Delaware
7. UD Education News: HHMI Award Supports Undergraduate Discovery
8. UD Environmental News: Pfiesteria Detectors To Be Described March 18
9. Researchers determine genetic cause of Timothy syndrome
10. Researchers find color sensitive atomic switch in bacteria
11. Researchers identify protein promoting vascular tumor growth

Post Your Comments:

(Date:12/4/2019)... Switzerland (PRWEB) , ... December 03, 2019 , ... ... biopharmaceutical R&D, today announced that Agenus , a clinical-stage immuno-oncology company developing ... of their antibody R&D workflow platform. Agenus will use the platform to support ...
(Date:12/4/2019)... , ... December 03, 2019 ... ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene ... a partnership with Ethicann Pharmaceuticals Inc. (“Ethicann”), a Calgary-based pharmaceutical company using ...
(Date:12/4/2019)... ... December 04, 2019 , ... NDA ... Todd , a regulatory toxicology expert with more than 20 years of experience ... , Dr. Todd has extensive experience with a variety of biologic modalities ...
Breaking Biology News(10 mins):
(Date:12/6/2019)... ANAHEIM, Calif. (PRWEB) , ... ... ... medical device manufacturer Vascular Medcure, Inc. has received FDA 510(k) clearance for ... treatment. The company’s early clinical data suggests the CAPERE® offers great benefits ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new survey by MedReps ( http://www.medreps.com ), ... the overall best medical sales companies to work for in 2020. , The ... 1,200 professionals from the MedReps community to identify which medical sales companies are currently ...
(Date:12/4/2019)... (PRWEB) , ... December 03, 2019 , ... ... antibody products and services, today announced a partnership with the Recombinant Antibody Network ... of Toronto, and UC San Francisco (UCSF) with a common goal to generate ...
(Date:12/4/2019)... POWAY, Calif. (PRWEB) , ... December 03, 2019 , ... ... went non-weightbearing lame on his right front leg. After several weeks of medical management, ... Dr. Mark Martinelli of California Equine Orthopedics . Results revealed Jesse had a ...
Breaking Biology Technology:
Cached News: